Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.54%
|
$380,000
$38.9 P/Share
|
|
Jun 14
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.34%
|
$10,000
$1.64 P/Share
|
|
Jun 10
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.07%
|
$412,596
$36.47 P/Share
|
|
Jun 10
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.91%
|
$11,461
$1.64 P/Share
|
|
Jun 08
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.07%
|
$401,135
$35.54 P/Share
|
|
Jun 08
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.91%
|
$11,461
$1.64 P/Share
|
|
May 28
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
264
-0.36%
|
$8,712
$33.87 P/Share
|
|
May 28
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
375
-0.18%
|
$12,375
$33.87 P/Share
|
|
May 28
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
802
-0.3%
|
$26,466
$33.87 P/Share
|
|
May 24
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.15%
|
$506,292
$31.44 P/Share
|
|
May 24
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.36%
|
$16,332
$1.64 P/Share
|
|
May 24
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
1,250
-11.76%
|
$38,750
$31.61 P/Share
|
|
May 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.53%
|
$310,000
$31.45 P/Share
|
|
May 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.34%
|
$10,000
$1.64 P/Share
|
|
May 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.53%
|
$300,000
$30.12 P/Share
|
|
May 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.34%
|
$10,000
$1.64 P/Share
|
|
May 17
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-20.9%
|
$72,500
$29.06 P/Share
|
|
May 14
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.19%
|
$178,640
$29.68 P/Share
|
|
May 14
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.7%
|
$6,160
$1.64 P/Share
|
|
May 13
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.19%
|
$178,640
$29.52 P/Share
|
|
May 13
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.7%
|
$6,160
$1.64 P/Share
|
|
May 06
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.06%
|
$343,830
$30.41 P/Share
|
|
May 06
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.9%
|
$11,461
$1.64 P/Share
|
|
May 04
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.06%
|
$343,830
$30.15 P/Share
|
|
May 04
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.9%
|
$11,461
$1.64 P/Share
|
|
May 03
2021
|
Dusty Tenney COO and President |
BUY
Grant, award, or other acquisition
|
Direct |
32,079
+50.0%
|
-
|
|
Apr 21
2021
|
Andrew G Hinson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,714
+34.69%
|
$10,714
$1.12 P/Share
|
|
Apr 21
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.53%
|
$320,000
$32.26 P/Share
|
|
Apr 21
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.34%
|
$10,000
$1.64 P/Share
|
|
Apr 20
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
650
-1.63%
|
$20,800
$32.1 P/Share
|
|
Apr 19
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.15%
|
$522,624
$32.58 P/Share
|
|
Apr 19
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.36%
|
$16,332
$1.64 P/Share
|
|
Apr 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.53%
|
$320,000
$32.62 P/Share
|
|
Apr 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.34%
|
$10,000
$1.64 P/Share
|
|
Apr 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.19%
|
$203,280
$33.38 P/Share
|
|
Apr 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.7%
|
$6,160
$1.64 P/Share
|
|
Apr 15
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-8.93%
|
$82,500
$33.8 P/Share
|
|
Apr 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.19%
|
$203,280
$33.76 P/Share
|
|
Apr 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.7%
|
$6,160
$1.64 P/Share
|
|
Apr 15
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-2.77%
|
$165,000
$33.69 P/Share
|
|
Apr 14
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-2.69%
|
$165,000
$33.83 P/Share
|
|
Apr 13
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,919
-1.91%
|
$382,165
$35.08 P/Share
|
|
Apr 13
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,919
+1.87%
|
$10,919
$1.7 P/Share
|
|
Apr 12
2021
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 12
2021
|
Todd Berard Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,362
+2.88%
|
-
|
|
Apr 12
2021
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,222
+1.71%
|
-
|
|
Apr 12
2021
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
8,487
+3.04%
|
-
|
|
Apr 12
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,854
+3.73%
|
-
|
|
Apr 12
2021
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Apr 12
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,360
+1.57%
|
-
|